Hepatitis B virus infection and transfusion medicine: Science and the occult

Transfusion

Volumn 48, Issue 5, 2008, Pages 1001-1026

  Hollinger, F Blaine ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; VIRUS DNA;

BLOOD DONOR; BLOOD TRANSFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; REVIEW; SCREENING TEST; SEROCONVERSION; VIREMIA; VIRUS DETECTION; VIRUS DIAGNOSIS;

BLOOD DONORS; BLOOD TRANSFUSION; CARRIER STATE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS;

EID: 42949142487     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01701.x     Document Type: Review

References (141)

1. Liang TJ, Baruch Y, Benporath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991 13 : 1044 51.
2. Paterlini P, Gerken G, Nakajima E, Terre S, Derrico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Brechot C. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990 323 : 80 5.
3. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli N, Chisari FV, Rehermann B, Del Prete G, Fiaccadori F, Ferrari C. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996 98 : 1185 94.
4. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994 68 : 2671 6.
5. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Kimura S, Koike K. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998 27 : 1377 82.
6. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993 17 : 538 44.
7. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007 14 (Suppl 1 11 5.
8. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A 1996 93 : 4398 402.
9. Ganem D. Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 1991 168 : 61 83.
10. Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, Kwiatkowski RW, Wright T, Lai CL, Condreay LD. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat 2007 14 : 55 63.
11. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004 126 : 1750 8.
12. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006 44 : 694 702.
13. Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991 88 : 1059 63.
14. Hollinger FB, Dressman GR, Fields H, Melnick J. HBcAg, anti-HBc, and DNA polymerase activity in transfused recipients followed prospectively. Am J Med Sci 1975 270 : 343 8.
15. Madejon A, Manzano ML, Arocena C, Castillo I, Carreno V. Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. J Hepatol 2000 32 : 1019 25.
16. Owiredu WK, Kramvis A, Kew MC. Hepatitis B virus DNAin serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. J Med Virol 2001 64 : 441 54.
17. Hui CK, Sun H, Au WY, Lie AK, Yueng YH, Zhang HY, Lee NP, Hou JL, Liang R, Lau GK. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005 42 : 813 9.
18. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
19. Gerlich WH, Glebe D, Schuttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007 14 (Suppl 1 16 21.
20. Kleinman S, Busch M, Rawal B, Glynn S, for the Retrovirus Epidemiology Donor Study. Evaluation of HBsAg neutralization test positive (neut pos) donors with negative (neg) anti-HBc. Transfusion 1998 38 (Suppl 92S.
21. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995 35 : 475 7.
22. Dow BC, Yates P, Galea G, Munro H, Buchanan I, Ferguson K. Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive blood donors. Vox Sang 2002 82 : 15 7.
23. Davis AR, Brotchie HL, Mundkur BA, Ismay SL. Transient hepatitis B surface antigenemia in a blood donor after a combination hepatitis A and B vaccine. Transfusion 2003 43 : 545.
24. Otag F. False positive HBsAg result in blood donors due to administration of three different recombinant DNA hepatitis B vaccines. Vaccine 2003 21 : 3734 7.
25. Sharma S, Saini N, Arora L, Chawla Y, Duseja A. Prolonged hepatitis B surface antigen positivity in hepatitis B vaccine recipients. Dig Liver Dis 2006 38 : 860 1.
26. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 : S23 S29.
27. Yugi H, Mizui M, Tanaka J, Yoshizawa H. Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. J Clin Virol 2006 36 : S56 S64.
28. Meisel H, Endres AS, Walter HU, Wend UC, Gerlich WH. Transmission of hepatitis B virus 2 months prior to hepatitis surface antigen positivity of donor blood. Transfus Med Hemother 2003 30 : 228 31.
29. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 1st ed. Boston, MA : Little, Brown 1985.
30. Zenilman JM, Miller WC, Gaydos C, Rogers SM, Turner CF. LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value. Sex Transm Infect 2003 79 : 94 7.
31. Tegtmeier GE, Katz LM, Stramer SL, Strong DM. Feasibility of reentry of donors deferred for repeated detection of antibody to hepatitis B core antigen (anti-HBc). Transfusion 2007 47 (Suppl 30A.
32. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
33. Robertson EF, Weare JA, Randell R, Holland PV, Madsen G, Decker RH. Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen. J Clin Microbiol 1991 29 : 605 10.
34. Spronk AM, Schmidt L, Krenc C, Pavlisjenkins L, Brady J, Taskar S, Angusfinn L, Mimms L. Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay. J Clin Microbiol 1991 29 : 611 6.
35. Cheng Y, Dubovoy N, Hayes-Rogers ME, Stewart J, Shah D. Detection of IgM to hepatitis B core antigen in a reductant containing, chemiluminescence assay. J Immunol Methods 1999 230 : 29 35.
36. Mushahwar IK, Dienstag JL, Polesky HF, Mcgrath LC, Decker RH, Overby LR. Interpretation of various serological profiles of hepatitis B virus infection. Am J Clin Pathol 1981 76 : 773 7.
37. Hollinger FB, Dolana G, Thomas W, Gyorkey F. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate. J Infect Dis 1984 150 : 250 62.
38. Hollinger FB, Liang TJ. Hepatitis B virus. In : Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia (PA Lippincott Williams & Wilkins 2001. p. 2971 3036.
39. Aoki SK, Finegold D, Kuramoto IK, Douville C, Richards C, Randell R, Fernando L, Holland PV, Zeldis JB. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion 1993 33 : 362 7.
40. Almeida NC, Strauss E, Sabino EC, Sucupira MC, Chamone DA. Significance of isolated hepatitis B core antibody in blood donors from Sao Paulo. Rev Inst Med Trop Sao Paulo 2001 43 : 203 8.
41. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, Koff RS, Petrini JL, Schiff ER, Shorey J, Stanley MM. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987 316 : 965 70.
42. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994 93 : 230 9.
43. Coffin CS, Pham TN, Mulrooney PM, Churchill ND, Michalak TI. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection. Hepatology 2004 40 : 1053 61.
44. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996 2 : 1104 8.
45. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. J Clin Microbiol 1999 37 : 68 73.
46. Yao JD, Beld MG, Oon LL, Sherlock CH, Germer J, Menting S, Thoe SY, Merrick L, Ziermann R, Surtihadi J, Hnatyszyn HJ. Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol 2004 42 : 800 6.
47. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989 339 : 237 8.
48. Niederhauser C, Hofelein C, Wegmuller B, Luthy J, Candrian U. Reliability of PCR decontamination systems. PCR Methods Appl 1994 4 : 117 23.
49. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003 112 : 145 51.
50. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001 80 : 63 71.
51. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003 84 : 287 91.
52. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004 44 : 1332 9.
53. Scullard GH, Greenberg HB, Smith JL, Gregory PB, Merigan TC, Robinson WS. Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment. Hepatology 1982 2 : 39 49.
54. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985 151 : 599 603.
55. Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Tabuchi A, Tanaka J, Yoshizawa H. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and C. Transfusion 2007 48 : 286 94.
56. Hsia CC, Purcell RH, Farshid M, Lachenbruch PA, Yu MY. Quantification of hepatitis B virus genomes and infectivity in human serum samples. Transfusion 2006 46 : 1829 35.
57. Wendel S, Levi JE, Biagini S, Candotti D, Allain J-P. A case of HBV transfusion-transmission revealed after a 13 month-long window period. Transfusion 2008 in press.
58. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007 47 : 1162 71.
59. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86.
60. Rawal BD, Kleinman SH, Kuhns MC, Busch MP. Infectious HBV window period and its projected reduction by genome amplification testing. Transfusion 1998 38 : 91S.
61. Kuhns MC, McNamara AL, Peterson B, DiMarco A, Satten GA. Detection of hepatitis B seroconversion by highly sensitive assays for surface antigen and HBV DNA. Transfusion 1998 38 : 91S.
62. Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, Vallari DV, Barbosa LH, Nemo GJ. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993 307 : 1095 7.
63. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004 86 : 83 91.
64. Gerlich WH, Luer W, Thomssen R. Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. J Infect Dis 1980 142 : 95 101.
65. Chau KH, Hargie MP, Decker RH, Mushahwar IK, Overby LR. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc. Hepatology 1983 3 : 142 9.
66. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001 43 : 187 90.
67. McIntyre A, Nimmo GR, Wood GM, Tinniswood RD, Kerlin P. Isolated hepatitis B core antibody - can response to hepatitis B vaccine help elucidate the cause? Aust N Z J Med 1992 22 : 19 22.
68. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983 2 : 1099 102.
69. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982 146 : 198 204.
70. Coursaget P, Yvonnet B, Chotard J, Vincelot P, Sarr M, Diouf C, Chiron JP, Diopmar I. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987 22 : 1 5.
71. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotoukarayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987 92 : 1844 50.
72. Sjogren MH, Lemon SM. Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. J Infect Dis 1983 148 : 445 51.
73. Tsuda F, Naito S, Takai E, Akahane Y, Furuta S, Miyakawa Y, Mayumi M. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 1984 87 : 159 64.
74. Tassopoulos NC, Sjogren MH, Purcell RH. 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage. Infection 1990 18 : 376 80.
75. Wang YM, Ng WC, Kang JY, Yap I, Seet BL, Teo J, Smith R, Guan R. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. Singapore Med J 1996 37 : 150 2.
76. Wang YM, Ng WC, Lo SK. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol 1999 34 : 600 6.
77. Hayashi J, Noguchi A, Nakashima K, Morofuji M, Kashiwagi S. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan. Gastroenterol Jpn. 1990 25 : 593 7.
78. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 1987 93 : 675 80.
79. Heijtink RA, Vanhattum J, Schalm SW, Masurel N. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease. J Med Virol 1982 10 : 83 90.
80. Tsang TK, Blei AT, O'Reilly DJ, Decker R. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity. Dig Dis Sci 1986 31 : 620 4.
81. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001 135 : 759 68.
82. Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 2005 77 : 173 9.
83. Zacharakis G, Koskinas J, Kotsiou S, Pouliou E, Papoutselis M, Tzara F, Vafeiadis N, Maltezos E, Archimandritis A, Papoutselis K. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece. J Pediatr Gastroenterol Nutr 2007 44 : 84 91.
84. Kocak N, Ozen H, Yuce A, Gurakan F. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels. Turk J Pediatr 1998 40 : 365 72.
85. Villeneuve JP, Desrochers M, Infanterivard C, Willems B, Raymond G, Bourcier M, Cote J, Richer G. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994 106 : 1000 5.
86. de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993 118 : 191 4.
87. Gigi E, Lalla T, Orphanou E, Sinakos E, Vrettou E, Raptopoulou-Gigi M. Long term follow-up of a large cohort of inactive HBsAg(+)/HBeAg(-)/anti-HBe(+) carriers in Greece. J Gastrointest Liver Dis 2007 16 : 19 22.
88. Gandhi MJ, Yang GG, McMahon BJ, Vyas GN. Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted. Transfusion 2000 40 : 910 6.
89. Grangeot-Keros L, Lambert T, Dubreuil P, Briantais MJ, Pillot J. False reactions in radioimmunoassay for viral hepatitis B markers in patients suffering from coagulation disorders. Vox Sang 1982 42 : 160 3.
90. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990 12 : 204 12.
91. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, Brechot C. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988 2 : 1273 6.
92. Coffin CS, Michalak TI. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999 104 : 203 12.
93. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995 35 : 5 12.
94. Aach RD, Alter HJ, Hollinger FB, Holland PV, Lander JJ, Melnick JL, Weiler JM. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Lancet 1974 2 : 190 3.
95. Dickson RC, Everhart JE, Lake JR, Wei YL, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH, and the National Institute of Diabetes and Digestive Diseases Liver Transplantation Database. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997 113 : 1668 74.
96. Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM. Reactivation of HBV replication in HIV-HBV infected patients. Am J Med 2003 114 : 768 9.
97. Clark SJ, Creighton S, Horner M, Smith HM, Portmann B, Taylor C, Cramp ME. Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression. Int J STD AIDS 2006 17 : 67 9.
98. Blanpain C, Knoop C, Delforge ML, Antoine M, Peny MO, Liesnard C, Vereerstraeten P, Cogan E, Adler M, Abramowicz D. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 1998 66 : 883 6.
99. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991 100 : 182 8.
100. Weinberger KM, Bauer T, Bohm S, Jilg WG. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000 81 : 1165 74.
101. Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994 199 : 292 300.
102. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and hepatitis C virus. J Hepatol 1995 23 : 14 20.
103. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 337 : 1733 45.
104. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol 1994 20 : 398 404.
105. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994 21 : 269 72.
106. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001 34 : 194 203.
107. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006 36 : S33 S44.
108. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
109. Linauts S, Saldanha J, Strong DM. PRISM HBsAg detection of HBV minipool NAT yield samples. Transfusion 2008 in press.
110. Chevrier MC, St Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007 47 : 1794 802.
111. O'Brien S, Fearon M, Yi QL, Fan W, Scalia V, Muntz I. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007 47 : 1809 15.
112. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999 107 : 186 95.
113. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002 100 : 2637 41.
114. Hourfar MK, Schmidt M, Roth W, Seifried E, Busch M, Wright D, Brixner V, Mayr-Wohlfart U, Schottstedt V, Pichl L, Weber-Schehl M, Jork C, Mahnhardt C, Gubbe K, Geusendam G. Experience of German Red Cross blood donor services with NAT-testing: results of screening more than 30 million blood donations for HIV-1, HCV, and HBV. Transfusion 2008 in press.
115. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006 44 : 1666 74.
116. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003 39 : S64 S69.
117. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007 47 : 74 9.
118. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007 47 : 1803 8.
119. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992 63 : 107 11.
120. Allen JG. Post-transfusion hepatitis, a serious clinical problem. Calif Med 1966 104 : 293 9.
121. Hoofnagle JH, Waggoner JG. Hepatitis A and hepatitis B virus markers in immune serum globulin. Gastroenterology 1980 78 : 259 63.
122. Katchaki JN, Siem TH, Brouwer R, Brandt KH, van der Waart M. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study. J Virol Methods 1980 2 : 119 25.
123. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990 30 : 431 2.
124. Hurlen B, Jacobsen N, Hurlen P. Hepatitis B serum markers and oral health in a group of Norwegian male prisoners. Acta Odontol Scand 1984 42 : 53 8.
125. Goldstein ST, Zhou FJ, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005 34 : 1329 39.
126. Yoshiba M, Sekiyama K, Sugata F, Kawamoto Y, Muraoka H, Aoyama M. Posttransfusion fulminant hepatitis B after screening for hepatitis B virus core antibody. Lancet 1992 339 : 253 4.
127. Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis - United States, 2005. Surveillance Summaries. MMWR 2007 56 (SS-3 1 9.
128. He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH. Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 1987 156 : 636 40.
129. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002 42 : 1592 7.
130. Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, Maruta A, Saito S, Yugi H, Hino M, Tadokoro K. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion 2006 46 : 2028 9.
131. Soldan K, Barbara JA, Dow BC. Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sang 2002 83 : 305 8.
132. Dow BC, Peterkin MA, Green RH, Cameron SO. Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA. Vox Sang 2001 81 : 140.
133. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007 47 : 1197 205.
134. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, Garcia-Herola A, Nicolas D, Carrasco D, Orbis JF, Mir J, Berenguer J. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001 7 : 51 8.
135. Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol 2006 45 : 127 43.
136. Gerlich WH. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 2006 36 : S18 S22.
137. Avettand-Fenoel V, Thabut D, Katlama C, Poynard T, Thibault V. Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection. J Clin Microbiol 2006 44 : 2250 3.
138. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004 14 : 97 103.
139. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001 41 : 329 32.
140. Pereira JS, Goncales NS, Silva C, Lazarini MS, Pavan MH, Fais VC, Goncales Jr. FL. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. Braz J Med Biol Res 2006 39 : 525 31.
141. Allain J-P. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Vox Sang 2007 92 : 254 7.